A Study of Boceprevir in Patients who have HIV and Hepatitis C

Mise à jour : Il y a 4 ans
Référence : EUCTR2008-004864-38

Femme et Homme

  • | Pays :
  • -
  • | Organes :
  • -
  • | Spécialités :
  • -

Extrait

The primary objective of this study is to compare the efficacy of boceprevir (PO) in combination with peginterferon alfa-2b (PEG2b) (SC) plus ribavirin weight-based dosing (WBD) PO to therapy with PEG2b plus ribavirin alone in adult subjects coinfected with human immunodeficiency virus (HIV) and previously untreated chronic hepatitis C virius (HCV) genotype 1.


Critère d'inclusion

  • Chronic hepatitis C